Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

PVR (CD155) Mouse anti-Human, Unconjugated, Clone: SKII.4, MilliporeSigma™

Mouse Monoclonal Antibody

$182.31 - $461.76

Specifications

Antigen PVR (CD155)
Clone SKII.4
Applications Flow Cytometry, Immunocytochemistry, Immunohistochemistry (Paraffin)
Classification Monoclonal
Conjugate Unconjugated
View More Specs

Products 2
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
Catalog Number Mfr. No. Quantity Price Quantity & Availability  
MABF22452MI
View Documents
MilliporeSigma
MABF224525UL
25 μL
Each for $182.31
Only null left
Add to Cart
 
MABF22451MI
View Documents
MilliporeSigma
MABF2245100UL
100 μL
Each for $461.76
Only null left
Add to Cart
 
Description

Description

PVR (CD155) Monoclonal antibody specifically detects PVR (CD155) in Human samples. It is validated for Flow Cytometry, Immunocytochemistry, Immunohistochemistry (Paraffin), Inhibits Activity/Function.
Specifications

Specifications

PVR (CD155)
Flow Cytometry, Immunocytochemistry, Immunohistochemistry (Paraffin)
Unconjugated
Mouse
Human
Poliovirus receptor;Nectin-like protein 5;NECL-5;CD155
SK-N-S1 human neuroblastoma cells
Primary
Stable for 1 year at -20°C from date of receipt.
45.31 kDa calculated.
SKII.4
Monoclonal
Purified
Cell Structure
NP_006496.4
PVR, PVS
IgG1 κ
Protein G Purified
Clone SKII.4 is a mouse monoclonal antibody that specifically detects human PVR (CD155).
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.